Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.91 USD
Change Today +0.05 / 2.69%
Volume 611.2K
MEIP On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

mei pharma inc (MEIP) Snapshot

Open
$1.91
Previous Close
$1.86
Day High
$1.97
Day Low
$1.89
52 Week High
10/13/14 - $8.33
52 Week Low
08/3/15 - $1.47
Market Cap
65.2M
Average Volume 10 Days
438.2K
EPS TTM
$-1.25
Shares Outstanding
34.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEI PHARMA INC (MEIP)

Related News

No related news articles were found.

mei pharma inc (MEIP) Related Businessweek News

No Related Businessweek News Found

mei pharma inc (MEIP) Details

MEI Pharma, Inc., an oncology company, focuses on the clinical development of drugs for the treatment of cancer. The company’s clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor, which is in Phase II clinical trial for the treatment of hematologic diseases, such as acute myeloid leukemia and myelodysplastic syndrome. Its clinical development pipeline also includes ME-344, an isoflavone-derived mitochondrial inhibitor drug candidate that is in Phase I clinical trial to treat refractory solid tumors; and PWT143, an oral inhibitor of phosphatidylinositide 3-kinase, which is in pre-clinical stage for the treatment of cancer. The company was formerly known as Marshall Edwards, Inc. and changed its name to MEI Pharma, Inc. in July 2012. MEI Pharma, Inc. was founded in 2000 and is based in San Diego, California.

mei pharma inc (MEIP) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $482.3K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $284.6K
Chief Medical Officer
Total Annual Compensation: $153.6K
Senior Vice President of Corporate Developmen...
Total Annual Compensation: $70.6K
Compensation as of Fiscal Year 2014.

mei pharma inc (MEIP) Key Developments

MEI Pharma, Inc. Reports Earnings Results for the Year Ended June 30, 2015

MEI Pharma, Inc. reported earnings results for the year ended June 30, 2015. For the year, the company reported loss from operations of $32,771,000 compared to $27,228,000 a year ago. Net loss was $32,694,000 or $1.16 per basic and diluted share compared to $27,148,000 or $1.35 per basic and diluted share a year ago. Net cash used in operations was $28.1 million for the year ended June 30, 2015, compared to $19.5 million for 2014.

MEI Pharma, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-11-2015 03:40 PM

MEI Pharma, Inc. Presents at Wedbush PacGrow Healthcare Conference 2015, Aug-11-2015 03:40 PM. Venue: Le Parker Meridian, 119 West 56th Street, New York, NY 10019, United States. Speakers: Daniel P. Gold, Chief Executive Officer, President and Director.

MEI Pharma, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 08:30 AM

MEI Pharma, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 08:30 AM. Venue: Le Parker Meridien Hotel, 119 W. 56th Street, New York, NY 10019, United States. Speakers: Daniel P. Gold, Chief Executive Officer, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MEIP:US $1.91 USD +0.05

MEIP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MEIP.
View Industry Companies
 

Industry Analysis

MEIP

Industry Average

Valuation MEIP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEI PHARMA INC, please visit www.meipharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.